ExpreS2ion Biotechnologies [Exprs2]

PROFILEExprs2 was listed on Nasdaq First North in Stockholm on July 29, 2016. See separate announcement HERE. Exprs2 delivers the essential technological component in future vaccines and immuno-therapeutics, patents pending. Based in Hørsholm, Denmark, Exprs2 aims to become the dominant protein production technology used in vaccine production. Founded in 2010 the company has partnered with…